Read Time: 2 mins

81/The role of 24-hour ambulatory 12-lead ECG in risk stratification in Brugada syndrome

Copy Link
Published Online: Oct 3rd 2008 European Journal of Arrhythmia & Electrophysiology. 2019;5(Suppl. 1):abstr81
Authors: R Williams (Presenting Author) - Royal Papworth Hospital, Cambridge, UK; K Divulwewa - Royal Papworth Hospital, Cambridge, UK; C Martin - Royal Papworth Hospital, Cambridge, UK; M Virdee - Royal Papworth Hospital, Cambridge, UK; S Agarwal - Royal Papworth Hospital, Cambridge, UK; D Begley - Royal Papworth Hospital, Cambridge, UK; P Heck - Royal Papworth Hospital, Cambridge, UK; S Fynn - Royal Papworth Hospital, Cambridge, UK; A Grace - Royal Papworth Hospital, Cambridge, UK; G Mellor - Royal Papworth Hospital, Cambridge, UK
Quick Links:
Article Information

Background: The presence of a spontaneous type 1 Brugada ECG pattern and previous syncope or cardiac arrest have consistently been associated with increased risk of sudden cardiac death (SCD) in Brugada Syndrome (BrS). In contrast asymptomatic individuals with a drug-induced type 1 pattern are at low risk. However, the ECG phenotype is known to be highly dynamic. We hypothesised ambulatory 12-lead ECG may be superior to ajmaline provocation for identifying patients with BrS and a moderate-to-high risk of arrhythmic events.

Methods: Patients with a previously documented type 1 Brugada ECG pattern (spontaneous, fever- or ajmaline-induced) underwent 12-lead 24-hour ambulatory ECG monitoring with modified high RV leads. Patients were classified as either ‘≥ Moderate Risk (previous spontaneous type 1 ECG pattern or previous arrhythmic syncope/cardiac arrest) or ‘Low Risk’ (Asymptomatic and a drug-induced ECG pattern only). The presence of Brugada ECG patterns and J-point amplitude (irrespective of ECG morphology) were recorded at 30 min intervals throughout 24 hours. The 24-hour ‘Type 1 burden’ was calculated as time present (hours) x number of leads present). Findings in ≥ Moderate Risk and Low Risk groups were compared.

Results: The cohort comprises 18 patients (78% probands, 72% male, mean age 39 ± 14 years). There were 7 (39%) patients classified as ≥ Moderate Risk and 11 (61%) as Low Risk. Prior spontaneous type 1 ECG was present in 6 (33%). Two patients had prior aborted cardiac arrest. An intermittent type 1 ECG was seen for ≥1 hour in 5 (28%) patients.

≥ Moderate Risk patients displayed a higher ‘type 1 burden’ in standard and high RV leads (18.0 ± 26.7 versus 0.1 ± 0.3 lead.hours, p=0.04) and sum J-point elevation over 24 hours (22.3 ± 27.6 versus 2.3 ± 3.3 mV, p=0.03) than low risk patients (see Figure 1). Prospective data collection and analysis is ongoing.

Conclusions: Ambulatory 12-lead ECG differentiates low risk from
≥ Moderate Risk patients and may be superior to ajmaline provocation in identifying patients with prognostically significant BrS. Sum J-point elevation over 24 hours may represent a novel risk marker for arrhythmic events in BrS.


Further Resources

Share this Article
Related Content In Arrhythmia
  • Copied to clipboard!
    accredited arrow-down-editablearrow-downarrow_leftarrow-right-bluearrow-right-dark-bluearrow-right-greenarrow-right-greyarrow-right-orangearrow-right-whitearrow-right-bluearrow-up-orangeavatarcalendarchevron-down consultant-pathologist-nurseconsultant-pathologistcrosscrossdownloademailexclaimationfeedbackfiltergraph-arrowinterviewslinkmdt_iconmenumore_dots nurse-consultantpadlock patient-advocate-pathologistpatient-consultantpatientperson pharmacist-nurseplay_buttonplay-colour-tmcplay-colourAsset 1podcastprinter scenerysearch share single-doctor social_facebooksocial_googleplussocial_instagramsocial_linkedin_altsocial_linkedin_altsocial_pinterestlogo-twitter-glyph-32social_youtubeshape-star (1)tick-bluetick-orangetick-red tick-whiteticktimetranscriptup-arrowwebinar Sponsored Department Location NEW TMM Corporate Services Icons-07NEW TMM Corporate Services Icons-08NEW TMM Corporate Services Icons-09NEW TMM Corporate Services Icons-10NEW TMM Corporate Services Icons-11NEW TMM Corporate Services Icons-12Salary £ TMM-Corp-Site-Icons-01TMM-Corp-Site-Icons-02TMM-Corp-Site-Icons-03TMM-Corp-Site-Icons-04TMM-Corp-Site-Icons-05TMM-Corp-Site-Icons-06TMM-Corp-Site-Icons-07TMM-Corp-Site-Icons-08TMM-Corp-Site-Icons-09TMM-Corp-Site-Icons-10TMM-Corp-Site-Icons-11TMM-Corp-Site-Icons-12TMM-Corp-Site-Icons-13TMM-Corp-Site-Icons-14TMM-Corp-Site-Icons-15TMM-Corp-Site-Icons-16TMM-Corp-Site-Icons-17TMM-Corp-Site-Icons-18TMM-Corp-Site-Icons-19TMM-Corp-Site-Icons-20TMM-Corp-Site-Icons-21TMM-Corp-Site-Icons-22TMM-Corp-Site-Icons-23TMM-Corp-Site-Icons-24TMM-Corp-Site-Icons-25TMM-Corp-Site-Icons-26TMM-Corp-Site-Icons-27TMM-Corp-Site-Icons-28TMM-Corp-Site-Icons-29TMM-Corp-Site-Icons-30TMM-Corp-Site-Icons-31TMM-Corp-Site-Icons-32TMM-Corp-Site-Icons-33TMM-Corp-Site-Icons-34TMM-Corp-Site-Icons-35TMM-Corp-Site-Icons-36TMM-Corp-Site-Icons-37TMM-Corp-Site-Icons-38TMM-Corp-Site-Icons-39TMM-Corp-Site-Icons-40TMM-Corp-Site-Icons-41TMM-Corp-Site-Icons-42TMM-Corp-Site-Icons-43TMM-Corp-Site-Icons-44TMM-Corp-Site-Icons-45TMM-Corp-Site-Icons-46TMM-Corp-Site-Icons-47TMM-Corp-Site-Icons-48TMM-Corp-Site-Icons-49TMM-Corp-Site-Icons-50TMM-Corp-Site-Icons-51TMM-Corp-Site-Icons-52TMM-Corp-Site-Icons-53TMM-Corp-Site-Icons-54TMM-Corp-Site-Icons-55TMM-Corp-Site-Icons-56TMM-Corp-Site-Icons-57TMM-Corp-Site-Icons-58TMM-Corp-Site-Icons-59TMM-Corp-Site-Icons-60TMM-Corp-Site-Icons-61TMM-Corp-Site-Icons-62TMM-Corp-Site-Icons-63TMM-Corp-Site-Icons-64TMM-Corp-Site-Icons-65TMM-Corp-Site-Icons-66TMM-Corp-Site-Icons-67TMM-Corp-Site-Icons-68TMM-Corp-Site-Icons-69TMM-Corp-Site-Icons-70TMM-Corp-Site-Icons-71TMM-Corp-Site-Icons-72